Dr. Goetz on Treatment Challenges for ESR1-Mutant Breast Cancer
August 16th 2019
Matthew P. Goetz, MD, consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic, discusses the treatment landscape of estrogen receptor (ER)–positive breast cancer and advances made within the last 5 years.